| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC1673 |
| Trial ID | NCT02965157 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD20 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma |
| Year | 2016 |
| Country | China |
| Company sponsor | Beijing Biohealthcare Biotechnology Co., Ltd |
| Other ID(s) | EY201605-19 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||
|
|||||||||